Benzinga | Mar 29, 2021 08:07AM EDT

Vallon Pharmaceuticals FY20 Net Loss ~$4.8M, Cash, Cash Equivalents ~$109K

Vallon Pharmaceuticals (NASDAQ:VLON) will report on Q4 2020.